Molecular resolution of a TNXA / TNXB CH-1 chimera and the non-chimeric TNXB allele in CAH-X
- 28 October 2026
- journal article
- Published by Bioscientifica in Journal of Molecular Endocrinology
- Vol. 77 (4)
Abstract
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency can co-occur with CAH-X syndrome, a connective tissue disorder caused by TNXB haploinsufficiency, resulting from TNXA/TNXB chimeric genes within the RCCX module. Here, we performed a family-based molecular investigation to define a complex RCCX rearrangement, confirm the TNXA/TNXB chimera architecture, and independently assess the non-chimeric TNXB allele in a phenotypically discordant father–daughter pair. The proband underwent targeted CYP21A2 variant screening, trio gene-specific CYP21A2 sequencing, and copy-number analysis by multiplex ligation-dependent probe amplification. TNXA/TNXB short-read data were examined at pseudogene-informative positions, and the rearranged allele was characterized by RCCX-spanning long-range PCR using CYP779F and Tena32F followed by sequencing. A separate 2,536 bp allele-specific PCR was used to interrogate the 3′ region of the non-chimeric TNXB allele. Gene-specific sequencing identified a maternally inherited c.137_138delinsGA p.(Pro46Arg) variant, classified as a variant of uncertain significance, while P050-C1 MLPA demonstrated a paternally inherited deletion involving all tested CYP21A2 exons and TNXB exon 35. Broader TNXB analysis with P155 showed no additional exon-level copy-number abnormality. Relative read balance at selected TNXA/TNXB-informative positions supported the suspected rearrangement. Sequencing of the approximately 8.5 kb RCCX-spanning amplicon established a CH-1-compatible architecture and restricted the recombination breakpoint to a 371 bp interval. No additional potentially clinically relevant variant was identified within the sequenced region of the non-chimeric TNXB allele. This study provides detailed molecular resolution of a TNXA/TNXB CH-1 rearrangement and illustrates the value and limitations of complementary allele-specific analyses in phenotypically discordant CAH-X families.Keywords
This publication has 23 references indexed in Scilit:
- Long-read sequencing: An effective method for genetic analysis of CYP21A2 variation in congenital adrenal hyperplasiaClinica Chimica Acta, 2023
- CAH-X Syndrome: Genetic and Clinical ProfileMolecular Diagnosis & Therapy, 2022
- Molecular genetic testing of congenital adrenal hyperplasia due to 21-hydroxylase deficiency should include CAH-X chimerasEuropean Journal of Human Genetics, 2021
- EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiencyEuropean Journal of Human Genetics, 2020
- High-Throughput Screening for CYP21A1P-TNXA/TNXB Chimeric Genes Responsible for Ehlers-Danlos Syndrome in Patients with Congenital Adrenal HyperplasiaThe Journal of Molecular Diagnostics, 2019
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Reverse-hybridization assay for rapid detection of common CYP21A2 mutations in dried blood spots from newborns with elevated 17-OH progesteroneClinica Chimica Acta, 2012
- Chimeric CYP21P/CYP21 and TNXA/TNXB genes in the RCCX moduleMolecular Genetics and Metabolism, 2005
- A Recessive Form of the Ehlers–Danlos Syndrome Caused by Tenascin-X DeficiencyNew England Journal of Medicine, 2001
- Tenascin–X deficiency is associated with Ehlers–Danlos syndromeNature Genetics, 1997